Results 21 to 30 of about 140 (69)

Enrichment analysis of functional groups within the stem cell-derived cardiopoietic transcriptome

open access: yes, 2011
Approximately half of all expression profiles in cardiopoietic cells are downregulated while a third do not change more than 1.5-fold compared to unstimulated embryonic stem cells. Upregulated genes account for >10% of all genes.
Randolph S Faustino (48222)   +3 more
core   +1 more source

Nodal network anchors orchestrate coordinated recruitment of specialized ontological classes to secure a developmental theme

open access: yes, 2011
Left: a five group K-means algorithm, 4 × 6 SOM, and QT filter were each used to independently dissect the transcriptome of embryonic stem cell (ES) derived cardiogenesis.
Randolph S Faustino (48222)   +3 more
core   +1 more source

Phenotypic changes and transcriptome dynamism during cardiac stem cell differentiation

open access: yes, 2011
Electron microscopy visualized morphological changes occurring during guided stem cell cardiogenesis (left column) with associated expression and distribution of the selected cardiac transcription factor MEF2C and the cardiac contractile protein α ...
Randolph S Faustino (48222)   +3 more
core   +1 more source

Hhex and cer1 mediate the Sox17 pathway for cardiac mesoderm formation in embryonic stem cells

open access: yes, 2014
Cardiac muscle differentiation in vivo is guided by sequential growth factor signals, including endoderm-derived diffusible factors, impinging on cardiogenic genes in the developing mesoderm.
Liu, Y   +9 more
core  

The Development of a Chemical Biology Pipeline for the Identification of Small Molecules that Induce Cardiopoiesis in Murine Embryonic Stem Cells [PDF]

open access: yes, 2012
High-Content Screening (HCS) is a form of high throughput screening (HTS) that couples automated microscopy with high throughput image analysis to quantify biological effects. Thus, it can be thought of as applied biology bridging basic bench research to
Bushway, Paul Jay
core  

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled chart-1 clinical trial

open access: yes, 2018
Aims Cardiopoietic cells, produced through cardiogenic conditioning of patients\u27 mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis ...
Beleslin, Branko   +19 more
core  

Analysing electrocardiographic traits and predicting cardiac risk in UK biobank. [PDF]

open access: yesJRSM Cardiovasc Dis, 2021
Ramírez J   +7 more
europepmc   +1 more source

Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. [PDF]

open access: yesNPJ Regen Med, 2020
Arrell DK   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy